Novartis

-$0.61 (-0.67%) Today
-$0.04 (-0.04%) As of 12:55 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate.

CEO
Vasant Narasimhan
Employees
105,794
Headquarters
Basel, Basel-Stadt (Basle Town)
Founded
1996

NVS Key Statistics

Market Cap
219.83B
Price-Earnings Ratio
22.85
Dividend Yield
2.29
Average Volume
1.90M
High Today
$91.28
Low Today
$90.74
Open Price
$91.06
Volume
1.14M
52 Week High
$98.52
52 Week Low
$77.04

NVS News

BenzingaJul 21

Recap: Novartis Q2 Earnings

Shares of Novartis (NYSE:NVS) decreased 0.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 22.06%
MarketWatchJul 21

Novartis 2Q Sales Beat Expectations as Sandoz Performed Better

By Cecilia Butini Novartis AG reported results for the second quarter on Wednesday. Here is what we watched. SALES: The Swiss pharmaceutical company posted sa
BenzingaJul 21

Novartis Posts Q2 Earnings Beat As Sales Pick Up; Reiterates 2021 Guidance

Novartis AG (NYSE: NVS) boosted its second-quarter core net income by 20% Y/Y to $3.7 billion, beating market expectations as it kept its 2021 guidance. Earnin

NVS Earnings

$1.25
$1.39
$1.52
$1.66
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$1.52 per share
Actual
$1.66 per share
Replay Earnings Call

More NVS News

MarketWatchJul 21

Novartis Backs Outlook as 2Q Net Profit, Sales Rose

Novartis AG said its sales and profit for the second quarter rose as its key growth drivers built momentum, and backed its outlook for the full year. The Swiss
ReutersJul 21

Novartis posts Q2 profit beat, keeps 2021 guidance

The logo of Swiss drugmaker Novartis is pictured at the company's headquarters in Rueil-Malmaison ZURICH (Reuters) -Novartis boosted its second-quarter core ne
BenzingaJul 20

Earnings Outlook For Novartis

On Wednesday, July 21, Novartis (NYSE:NVS) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings,
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure